ArticlePharmacoEconomics2005
Modelling the cost effectiveness of cholinesterase inhibitors in the management of mild to moderately severe Alzheimer's disease.
Colin Green et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this paperpooled itcites it